At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

NCT ID: NCT01931644

Last Updated: 2024-04-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

17667 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-07-31

Study Completion Date

2024-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. We make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will collect blood and other optionally donated tissue samples from people with all different types of health conditions, as well as healthy control samples, in order to provide biomedical researchers with quality biospecimens that are necessary in translating basic science research into clinically relevant information and technology.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

All Diagnosed Health Conditions ADD/ADHD Alopecia Areata Ankylosing Spondylitis Asthma Atopic Dermatitis Eczema Beta Thalassemia Bipolar Disorder Breast Cancer Celiac Disease Cervical Cancer Chronic Inflammatory Demyelinating Polyneuropathy Chronic Kidney Diseases Chronic Obstructive Pulmonary Disease Colon Cancer Colorectal Cancer Crohn's Disease Cystic Fibrosis Depression Diabetes Mellitus Duchenne Muscular Dystrophy Endometriosis Epilepsy Facioscapulohumeral Muscular Dystrophy G6PD Deficiency General Anxiety Disorder Hepatitis B Hereditary Hemorrhagic Telangiectasia HIV/AIDS Human Papilloma Virus Huntington's Disease Idiopathic Thrombocytopenic Purpura Insomnia Kidney Cancer Leukemia Lung Cancer Lupus Nephritis Lymphoma Melanoma Multiple Myeloma Multiple Sclerosis Myositis Myotonic Dystrophy Ovarian Cancer Pancreatic Cancer Parkinson's Disease Polycystic Kidney Diseases Prostate Cancer Psoriasis Psoriatic Arthritis Rosacea Scleroderma Sickle Cell Anemia Sickle Cell Trait Sjogren's Syndrome Skin Cancer Spinal Muscular Atrophy Systemic Lupus Erythematosus Thrombotic Thrombocytopenic Purpura Trisomy 21 Ulcerative Colitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Health Condition

Collect blood and other optional biospecimens from participants with a diagnosed health condition

No interventions assigned to this group

Healthy Control

Collect blood and other optional biospecimens from participants that have not been diagnosed with a health condition

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All adults 18-100 years old
* Able to provide proof of diagnosis
* Live in USA

Exclusion Criteria

* Younger than 18 years old
* Receipt of blood products within 30 days of study blood collection
* Receipt of investigational drug within 30 days of study blood collection
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sanguine Biosciences

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Houman Hemmati, MD

Role: PRINCIPAL_INVESTIGATOR

Sanguine Biosciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sanguine Biosciences

Los Angeles, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SAN-BB-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.